본문 바로가기 대메뉴 바로가기

KAIST

NEWS

홈페이지 통합검색

-
KOREAN

%77%61%73%68%61%62%6c%65%20%6e%61%6e%6f%2d%66%69%62%65%72%20%66%69%6c%74%65%72%65%64%20%66%61%63%65%20%6d%61%73%6b

Antivirus Industry the Centerpiece of New Deal R&D Initiatives - KAIST launches post-COVID-19 R&D initiatives for smart mobile medical systems. - KAIST will make the antivirus industry the centerpiece of what it is touting as the KAIST New Deal R&D initiative, which will drive new growth engines for preparing for the post-coronavirus era. According to the new initiative, KAIST will concentrate on creating antivirus technologies, infectious disease-related big data management, and non-contact services platforms as key future R&D projects. President Sung-Chul Shin launched the COVID-19 R&D Initiative task force last month, composed of more than 50 professors from the Graduate School of Medical Science and Engineering, the Department of Biological Sciences, the College of Engineering, and the Department of Industrial Design. The task force came up with key research agendas that will promote smart mobile medical systems in the years ahead. “We will devote all of our R&D capacities to pursue a smart healthcare society,” said President Shin. “Our competitiveness in the fields of AI, ICT, materials, and bio-technology holds significant potential for building a healthy society powered by smart medical systems in Korea,” he added. The smart medical systems focus mainly on building an Epidemic Mitigating Mobile Module (EMMM). The EMMM will manage epidemics via the three phases of prevention, emergency response, and treatment, with the development of each phase’s technological modules. The EMMM will also build an AI big data platform to assist with clinical applications and epidemic management. Technologies applicable for the prevention phase include developing recyclable antivirus masks, plasma virus sterilizers, and smart breathable protective gowns. KAIST researchers will also focus on developing diagnosis modules that will identify epidemics more quickly and accurately. Most significantly, KAIST aims to develop technologies for anti-infection medical services such as the transformable negative pressure ambulance module and negative pressure room, which are specially developed for respiratory infections. The new R&D initiatives will center on virus therapies and treatments, specifically pushing forward vaccine and robotics studies. As caring robots and delivery robots will become common as main caregivers via noncontact services, research focusing on robotics will be significantly enhanced. Even before launching the new R&D initiatives, researchers have started to present new technologies to help address the pandemic. Professor Il-Doo Kim’s team in the Department of Materials Science and Engineering developed a washable nano-fiber filtered face mask that is preparing for commercialization. GPS tracking of infections has expanded comprehensively to detect both indoor and outdoor activities of infected patients. Professor Dong-Soo Han from the School of Computing developed Wi-Fi positioning software built into mobile phones that can trace both activities and is now preparing to roll it out. Virologist Ui-Cheol Shin from the Graduate School of Medical Science and Engineering is carrying out research on a universal T-cell vaccine that can block the Betacoronaviruses. It is reported that that new epidemics such as SARS, MERS, and COVID-19 carry Betacoronaviruses. Research teams in the Graduate School of AI are conducting various research projects on building prediction models for outbreaks and spreads using big data. (END)
2020.05.20 View 18353